Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.
This month we are presenting the annual life science market trend report for Germany that was created thanks to the cooperation with our partners: BIO Deutschland, HEALTH MADE IN GERMANY, Cluster Biotechnology North Rhine-Westphalia, and BioRN. With about 1,200 active companies, over 500 assets available for licensing and 478 million dollars of venture capital attracted … Continue reading German Life Science Market Trend Analysis 2020
Biotechgate presents the annual Trend Analysis Report 2020 for the Dutch life sciences sector. The report shows a stable number of life science companies and a sector which has grown in maturity. Biotech companies were successful in attracting venture capital; 2019 is a record year for venture financing.
The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the … Continue reading Denmark Life Science Market Trend Analysis 2020
South Korea is one of the most active life science markets in the world. In 2019, USD 806.7m was invested in Korean private biotech companies that accounted for almost 4% of the total global biotech financing amount. The country currently offers hundreds of biotech and medtech assets to out-licence. We would like to thank our … Continue reading Korean Life Science Market Trend Analysis 2020
Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.
Zurich 03 March 2020 Last month Biotechgate/Venture Valuation entered a partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, with the goal to develop and run a publicly accessible directory of companies located in the region. The Directory has recently been launched and is accessible for free on BioRN’s website. While it … Continue reading The Launch of the Rhine-Main-Neckar Directory
The number of financing rounds scored by UK private biotech companies in 2019 was the lowest since 2016. However, it still stays at a decent level and there is no sign of the British life science industry losing its position as the largest in Europe. Biotechgate lists more than 4,000 British companies that altogether have … Continue reading UK Life Science Market Trend Analysis 2020
This month we are presenting the annual trend report for the Canadian life science market that shows the strong position of the country in the global biotech industry. The total financing amount of the three largest rounds of 2019 alone exceeded a quarter billion USD. Download the report Would you like to be notified about … Continue reading Canadian Life Science Market Trend Analysis 2019
We are proud to present the annual trend report for the German life sciences market. The report was compiled using data gathered from Biotechgate Business Development Database, in cooperation with our partners: HEALTH MADE IN GERMANY, BIO Deutschland, Cluster Biotechnology North Rhine-Westphalia, and BioValley Germany. Download the report Would you like to be notified about … Continue reading German Life Sciences Market Trend Analysis 2019